Since 2015, Onkos has been working on research and development of state-of-the-art medical technologies, together with some of the largest centers of excellence in Brazil and in the world. Check out a summary of our history below.
INFRASTRUCTURE
RESEARCH AND DEVELOPMENT
2015
Cancer Hospital of Barretos and Supera Parque.
01
2015
Development of the mir-THYpe test (PIPE 1 Fapesp)
02
2017-2018
Development of a classifier for prostate cancer (PIPE 1 Fapesp)
03
2018
Laboratory inside USP Ribeirão Preto.
04
2018
Market launch of mir-THYpe.
05
NOV - 2018
Own laboratory in Ribeirão Preto and partnership with Eretz Bio
06
2018 - 2020
Optimization of the mir-THYpe test (PIPE 2 Fapesp)
07
2018
Publication in the journal Thyroid (belonging to the American Thyroid Association - ATA) of the results of the development and validation of the mir-THYpe test
08
JAN 2020
Launch of BRAF V600E + TERT mutations in mir-THYpe.
09
2020 - 2021
Move to a new 600m2 laboratory in Ribeirão Preto.
10
2020 - 2021
Development of a classifier for medullary thyroid cancer (PIPE1 Fapesp).
11
NOV - 2021
Market expansion for mir-THYpe (PIPE3 Fapesp).
12
2022
Launch of the mir-THYpe pre-op molecular test.
13
2022
Study published in The LANCET Discovery Science (eBioMedicine).
14
2022
Optimization of the mir-THYpe algorithm.
15
2022
Development of test of tumor origin (PIPE 2 FAPESP).
16
2023
Launch of the new molecular tests mir-THYpe target and mir-THYpe RET-hereditary.